Letter to the Editor: "Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes" by Holmegard HN, et al. (2016)

First Author: Abbasi A
Attributed to:  Aetiology of type 2 diabetes and related metabolic disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1210/jc.2015-4111

PubMed Identifier: 26840109

Publication URI: http://europepmc.org/abstract/MED/26840109

Type: Journal Article/Review

Volume: 101

Parent Publication: The Journal of clinical endocrinology and metabolism

Issue: 2

ISSN: 0021-972X